Merck France CEO Thierry Houlot has been elected president of Leem, the pharmaceutical industry’s professional federation, for a two-year term, succeeding Frédéric Collet, the federation said on Wednesday.
Thierry Hulot, 58, has a specialization in pharmacology and drug metabolism from René Descartes University and Paris Sud. He also holds an MBA from Ashridge University, UK. He began his career in 1989 at the Delagrange laboratory before joining Synthélabo Recherche. He then joined the German pharmaceutical company Merck in 1995, where he held various positions before becoming Group President for France in 2017.
The new president of Lim wants specifically.protect the growth model for mature medicines (long-term development: editor’s note) and for innovative medicines to guarantee their long-term access to patients“. “I am convinced that achieving this requires a strong industry supported by a strong, ambitious professional association that will be present in all areas of the pharmaceutical value chain.“, he emphasizes, quoted in the press release. Thierry Hulot succeeds Frédéric Collet, who managed Lim in 2019 when he was French president of the Swiss laboratory Novartis.
Source: Le Figaro
I’m Liza Grey, an experienced news writer and author at the Buna Times. I specialize in writing about economic issues, with a focus on uncovering stories that have a positive impact on society. With over seven years of experience in the news industry, I am highly knowledgeable about current events and the ways in which they affect our daily lives.